RELIBETA 30MCG INJECTION belongs to the class of medicines called immunomodulators indicated in the treatment of relapsing forms of multiple sclerosis. It helps reduce the number and severity of relapses and slow the progression of disability.
RELIBETA 30MCG INJECTION contains Interferon beta-1A that works by decreasing inflammation and preventing nerve damage which may cause symptoms of multiple sclerosis.
In some cases, RELIBETA 30MCG INJECTION may cause side effects such as injection site reactions, headache, diarrhoea, nausea, vomiting, fatigue, and insomnia. You are advised to talk to your doctor if any of the side effects persist or worsen.
Consult the doctor if you are pregnant or breastfeeding. RELIBETA 30MCG INJECTION is not recommended for children below 2 years. Inform your doctor about all the medicines you are taking and your health condition to rule out any unpleasant side effects/interactions.